关注
Dr. Ritchu Babbar
Dr. Ritchu Babbar
Professor
在 chitkara.edu.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
NOVEL HERBS USED IN COSMETICS FOR SKIN AND HAIR CARE : A REVIEW
SARB Arashmeet Kaur, Thakur Gurjeet Singh, Sonia Dhiman
Plant archives 20 (1), 3784-3793, 2020
292020
A comprehensive review on therapeutic applications of ferulic acid and its novel analogues: A brief literature
R Babbar, S Dhiman, R Grover, A Kaur, S Arora
Mini Reviews in Medicinal Chemistry 21 (12), 1578-1593, 2021
212021
An insight on novel approaches & perspectives for gastro-retentive drug delivery systems
S Dhiman, N Philip, T Gurjeet Singh, R Babbar, N Garg, V Diwan, P Singh
Current Drug Delivery 20 (6), 708-729, 2023
152023
Synthesis, characterization and molecular Docking studies of novel N-(benzimidazol-1-ylmethyl)-4-chlorobenzamide analogues for potential anti-inflammatory and antimicrobial …
R Sethi, S Jain, S Arora, D Saini, N Jain
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly …, 2018
132018
A systematic review on 1, 4-Dihydropyridines and its analogues: An elite scaffold
VD Ann Riya Ninan 1 , Ritchu Babbar * , Sonia Dhiman, Thakur Gurjeet Singh ...
Biointerface Research In Applied Biochemistry 12 (3), 3117-3134, 2021
12*2021
Angiogenic footprints in diabetic retinopathy: opportunities for drug development
MH Bhatia, S., Babbar, R., Zehravi, M., ...Khan, F.S., Rahman
Biotechnology and Genetic Engineering Reviews, 2022
11*2022
PHYTOCHEMICAL ACTIVITIES AND PHARMACOLOGY OF HERBAL DRUG: NARDOSTACHYS JATAMANSI
SATGS Sonia Dhiman, Govind Arora, Aastha Thukral, Ritchu Babbar
Plant archives 20 (1), 3842-3848, 2020
82020
Synthesis, Characterization, Molecular Docking Studies and Antimicrobial Evaluation of N-Benzimidazol-1-Yl-Methyl-Benzamide Derivatives
R Sethi, S Arora, D Saini, S Jain
Indian Journal of Pharmaceutical Education and Research 50 (3), 424-434, 2016
82016
SYNTHESIS AND ANTI-INFLAMMATORY ACTIVITY OF MANNICH BASES OF NICOTINAMIDE WITH DICLOFENAC AND MEFENAMIC ACID
NJSJ Ritchu Babbar , D.P. Pathak
Der Pharma Chemica 4 (5), 2024-2028, 2012
82012
The current landscape of bioactive molecules against DENV: A systematic review
R Babbar, R Kaur, P Rana, S Arora, T Behl, M Albratty, A Najmi, ...
Evidence‐Based Complementary and Alternative Medicine 2023 (1), 2236210, 2023
72023
Acetylcholinesterase inhibitors: a milestone to treat neurological disorders
A Kaur, C Anand, TG Singh, S Dhiman, R Babbar
Plant Arch 19, 1347-1359, 2019
72019
A comprehensive review on therapeutic potential of Benzimidazole: A miracle scaffold
R Babbar, S Arora
Journal of Pharmaceutical Technology, Research and Management 8 (1), 23-29, 2020
62020
Synthesis and characterization of some new twin drugs having substituted pyridines
RBDP Pathak
Der Pharma Chemica 5 (4), 147-152, 2013
52013
Evolving advances in the cosmetic use of probiotics and postbiotics: health, regulatory and marketing aspects
R Arora, R Kaur, R Babbar, S Dhingra, AK Dhingra, AS Grewal
Current Pharmaceutical Biotechnology 25 (11), 1349-1361, 2024
42024
General Aspects, Applications, and Recent Advancements of 1, 2-Disubstituted Benzimidazole Mannich Bases: A Privileged Scaffold
Babbar, Ritchu, Makkar, Swikriti
ECS Transactions 107 (1), 10631, 2022
42022
Mannich Bases of 2-Substituted Benzimidazoles-A Review
R Sethi, S Arora, N Jain, S Jain
Journal of Pharmaceutical Technology, Research and Management 3 (2), 97-111, 2015
42015
Recent insights into synthesis, biological activities, structure activity relationship and molecular interactions of thiazolidinone hybrids: A systematic review
S Parveen, R Babbar, VN Badavath, SK Nath, S Kumar, R Rawat, ...
Synthetic Communications 54 (1), 1-21, 2024
32024
Design and synthesis of neoteric benzylidene amino-benzimidazole scaffolds for antioxidant and anti-inflammatory activity
Swikriti, R Babbar, D Saini, R Rawat, S Chigurupati, SG Felemban, ...
Future Medicinal Chemistry 15 (10), 813-828, 2023
32023
Design and Synthesis of N-(benzimidazol-1-yl Methyl)-Benzamide Derivatives Anti-inflammatory and Analgesic Agents
R Sethi, S Arora, D Saini, TG Singh, S Jain
ACTA Pol. Pharm 74, 1413-1425, 2017
32017
PARP: Novel therapeutic target to treat cancer and inflammatory diseases
R Sethi, S Jain
World J Pharm Pharm Sci 3 (12), 469-494, 2014
32014
系统目前无法执行此操作,请稍后再试。
文章 1–20